Recruiting Preeclampsia Studies in Galveston
Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide
Postpartum prophylactic HCTZ administration for prevention and relapse of preeclampsia or gestational hypertension....
Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)
To conduct an unblinded pragmatic randomized controlled trial (pRCT) "Improvement of PPROM Management with Prophylactic Antimicrobial Therapy (iPROMPT)" of a seven-day course of ceftriaxone, clarithro...
About Preeclampsia Clinical Trials in Galveston
Preeclampsia is a pregnancy complication characterized by high blood pressure and signs of damage to organs, most often the liver and kidneys. It usually develops after 20 weeks of pregnancy and can be life-threatening. Treatment may include early delivery, blood pressure medications, and close monitoring.
There are currently 2 preeclampsia clinical trials recruiting participants in Galveston, TX. These studies are seeking a combined 668 participants. Research is being sponsored by The University of Texas Medical Branch, Galveston, Ohio State University. Clinical trial participation is free and participants receive study-related medical care at no cost.
Preeclampsia Clinical Trials in Galveston — FAQ
Are there preeclampsia clinical trials in Galveston?
Yes, there are 2 preeclampsia clinical trials currently recruiting in Galveston, TX. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Galveston?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Galveston research site will contact you about next steps.
Are clinical trials in Galveston free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Galveston studies also compensate for your time and travel.
What preeclampsia treatments are being tested?
The 2 active trials in Galveston are testing new therapies including novel drugs, biologics, and treatment approaches for preeclampsia.
Data updated March 2, 2026 from ClinicalTrials.gov